Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT06928116 · University of Nebraska

Heat thErapy And mobiLity in COVID-19 Survivors

(HEAL)

What this study is about

Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC.

View original scientific description

Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".

Interventions

BEHAVIORAL

Heat therapy

At home lower body heat therapy

BEHAVIORAL

Sham Control

Sham Thermoneutral

BEHAVIORAL

Walking

Walking intervention

Primary outcome measures

6 min walking distance

Time frame: 8 weeks

Distance covered during 6 min of walking

Short Physical Performance Battery Test

Time frame: 8 weeks

Test of physical functional capacity

Arterial stiffness

Time frame: 8 weeks

Pulse Wave velocity

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Between the ages of 50 and 90 years
  • Free from orthopedic limitations that would prohibit performing leg exercise
  • BMI \< 40 kg/m2 and weigh \< 400lbs
  • Previously contracted Covid-19 and have persistent symptoms such as a fatigue or decline in physical function, for at least 2 months following SARS-CoV-2 infection

Exclusion criteria

  • Unable to give written informed consent
  • Women who are pregnant, breastfeeding, or likely to become pregnant within the next 6 months
  • Women who are taking hormone therapy
  • Claustrophobia
  • Orthopedic limitations that would prohibit them from walking
  • Currently enrolled in an exercise-based or respiratory muscle rehabilitation program.

Where

  • Omaha, Nebraska

Collaborators

National Institute on Aging (NIA)

Related conditions & keywords

Long COVIDHeat Therapymobility limitationsPost-acute sequelae of SARS-CoV-2 infection (PASC)

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Oct 23, 2025 · Source of record for eligibility and locations

📊
1 of 99 participants interested
1% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Omaha

Nebraska

Location available
View Omaha location page

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More COVID-19 Trials by City

Browse all covid-19 clinical trials in these cities — not just this study.

Looking for Long COVID Treatment in Omaha?

Join others in Nebraska exploring innovative treatment options through clinical research

Long COVID Treatment Options in Omaha, Nebraska

If you're searching for Long COVID treatment in Omaha, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Omaha and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Long COVID. All study-related care is provided at no cost to participants.

Local Sites
1 locations in Nebraska
Now Enrolling
Up to 99 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Long COVID?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Long COVID

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Long COVID Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06928116. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.